260 related articles for article (PubMed ID: 15199074)
1. Application of Bayes theorem to aminoglycoside-associated nephrotoxicity: comparison of extended-interval dosing, individualized pharmacokinetic monitoring, and multiple-daily dosing.
Kim MJ; Bertino JS; Erb TA; Jenkins PL; Nafziger AN
J Clin Pharmacol; 2004 Jul; 44(7):696-707. PubMed ID: 15199074
[TBL] [Abstract][Full Text] [Related]
2. Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis.
Graham AC; Mercier RC; Achusim LE; Pai MP
Ann Pharmacother; 2004 Jun; 38(6):936-41. PubMed ID: 15084688
[TBL] [Abstract][Full Text] [Related]
3. Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis.
Prescott WA; Nagel JL
Pharmacotherapy; 2010 Jan; 30(1):95-108. PubMed ID: 20030477
[TBL] [Abstract][Full Text] [Related]
4. Intravenous aminoglycoside usage and monitoring of patients with cystic fibrosis in Australia. What's new?
Soulsby N; Bell S; Greville H; Doecke C
Intern Med J; 2009 Aug; 39(8):527-31. PubMed ID: 19220547
[TBL] [Abstract][Full Text] [Related]
5. [Daily single-dose aminoglycoside administration. Therapeutic and economic benefits].
Knudsen LM; Frimodt-Møller N; Hansen MT; Hippe E
Ugeskr Laeger; 1993 May; 155(19):1436-41. PubMed ID: 8316969
[TBL] [Abstract][Full Text] [Related]
6. Aminoglycoside nephrotoxicity.
Swan SK
Semin Nephrol; 1997 Jan; 17(1):27-33. PubMed ID: 9000547
[TBL] [Abstract][Full Text] [Related]
7. Outcome of patients treated by an aminoglycoside pharmacokinetic dosing service.
Sveska KJ; Roffe BD; Solomon DK; Hoffmann RP
Am J Hosp Pharm; 1985 Nov; 42(11):2472-8. PubMed ID: 4073064
[TBL] [Abstract][Full Text] [Related]
8. Chronopharmacokinetics of once daily dosed aminoglycosides in hospitalized infectious patients.
van Maarseveen E; Man WH; Proost J; Neef C; Touw D
Int J Clin Pharm; 2015 Apr; 37(2):342-7. PubMed ID: 25616626
[TBL] [Abstract][Full Text] [Related]
9. Mega-analysis of meta-analysis: an examination of meta-analysis with an emphasis on once-daily aminoglycoside comparative trials.
Freeman CD; Strayer AH
Pharmacotherapy; 1996; 16(6):1093-102. PubMed ID: 8947983
[TBL] [Abstract][Full Text] [Related]
10. A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function.
Sweileh WM
Fundam Clin Pharmacol; 2009 Aug; 23(4):515-20. PubMed ID: 19709328
[TBL] [Abstract][Full Text] [Related]
11. Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring.
Croes S; Koop AH; van Gils SA; Neef C
Eur J Pharm Sci; 2012 Jan; 45(1-2):90-100. PubMed ID: 22094306
[TBL] [Abstract][Full Text] [Related]
12. [Individualized monitoring of the therapy with gentamycin using pharmacokinetic methods. Which method to choose?].
Carvalho A; Fonseca C; Falcão F; Pereira TA; Freitas O; Parrinha A; Costa M; Rodrigues MJ; Ceia F; Luís AS
Acta Med Port; 1996; 9(7-9):187-95. PubMed ID: 9005695
[TBL] [Abstract][Full Text] [Related]
13. Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis.
Nestaas E; Bangstad HJ; Sandvik L; Wathne KO
Arch Dis Child Fetal Neonatal Ed; 2005 Jul; 90(4):F294-300. PubMed ID: 15857879
[TBL] [Abstract][Full Text] [Related]
14. Aminoglycosides--50 years on.
Begg EJ; Barclay ML
Br J Clin Pharmacol; 1995 Jun; 39(6):597-603. PubMed ID: 7654476
[TBL] [Abstract][Full Text] [Related]
15. Aminoglycoside nephrotoxicity: pathogenesis and prevention.
Cronin RE
Clin Nephrol; 1979 May; 11(5):251-6. PubMed ID: 378495
[TBL] [Abstract][Full Text] [Related]
16. Aminoglycoside monitoring: use of a pharmacokinetic service versus physician recommendations.
Smith M; Murphy JE; Job ML; Ward ES
Hosp Formul; 1987 Jan; 22(1):92-9, 102. PubMed ID: 10280287
[TBL] [Abstract][Full Text] [Related]
17. Drug usage evaluation of aminoglycoside-induced nephrotoxicity in a community hospital.
Wade WE; McCall CY
Hosp Formul; 1990 Oct; 25(10):1092-4, 1096. PubMed ID: 10107391
[TBL] [Abstract][Full Text] [Related]
18. Management of aminoglycosides in the intensive care unit.
Radigan EA; Gilchrist NA; Miller MA
J Intensive Care Med; 2010; 25(6):327-42. PubMed ID: 20837630
[TBL] [Abstract][Full Text] [Related]
19. Single daily dosing of aminoglycosides.
Preston SL; Briceland LL
Pharmacotherapy; 1995; 15(3):297-316. PubMed ID: 7667165
[TBL] [Abstract][Full Text] [Related]
20. Risk of nephrotoxicity with combination vancomycin-aminoglycoside antibiotic therapy.
Pauly DJ; Musa DM; Lestico MR; Lindstrom MJ; Hetsko CM
Pharmacotherapy; 1990; 10(6):378-82. PubMed ID: 2287556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
